1. Ruxolitinib for symptom control in patients with chronic lymphocytic leukaemia: a single-group, phase 2 trial. Issue 2 (February 2017) Authors: Jain, Preetesh; Keating, Michael; Renner, Sarah; Cleeland, Charles; Xuelin, Huang; Gonzalez, Graciela Nogueras; Harris, David; Li, Ping; Liu, Zhiming; Veletic, Ivo; Rozovski, Uri; Jain, Nitin; Thompson, Phillip; Bose, Prithviraj; DiNardo, Courtney; Ferrajoli, Alessandra; O'Brien, Susan; Burger, J... Journal: Lancet Issue: Volume 4:Issue 2(2017) Page Start: e67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms)⧉